3 Stocks Pushing The Health Care Sector Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 24 points (-0.2%) at 14,029 as of Friday, March 1, 2013, 11:49 AM ET. The NYSE advances/declines ratio sits at 1,249 issues advancing vs. 1,609 declining with 131 unchanged.

The Health Care sector currently is unchanged today versus the S&P 500, which is unchanged. Top gainers within the sector include Celgene Corporation ( CELG), up 1.4%, Regeneron Pharmaceuticals ( REGN), up 1.2%, Express Scripts ( ESRX), up 0.6%, Stryker Corporation ( SYK), up 0.8% and Amgen ( AMGN), up 0.5%. On the negative front, top decliners within the sector include Medivation ( MDVN), down 6.6%, ResMed ( RMD), down 2.0% and Sanofi ( SNY), down 0.6%.

TheStreet Ratings group would like to highlight 3 stocks pushing the sector higher today:

3. Baxter International ( BAX) is one of the companies pushing the Health Care sector higher today. As of noon trading, Baxter International is up $0.63 (0.9%) to $68.23 on light volume Thus far, 901,864 shares of Baxter International exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $67.21-$68.32 after having opened the day at $67.36 as compared to the previous trading day's close of $67.60.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $36.7 billion and is part of the health services industry. The company has a P/E ratio of 16.1, below the S&P 500 P/E ratio of 17.7. Shares are up 1.0% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Baxter International Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

These Stocks Are Ready to Reverse Course

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways